Fortress Biotech, Inc. 13D and 13G filings for Avenue Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-02 5:00 pm Purchase | 2025-03-31 | 13D | Avenue Therapeutics, Inc. ATXI | Fortress Biotech Inc. FBIO | 328,746 10.300% | 33,724 (+11.43%) | Filing |
| 2025-01-03 5:50 pm Purchase | 2024-12-31 | 13D | Avenue Therapeutics, Inc. ATXI | Fortress Biotech Inc. FBIO | 295,022 13.800% | 114,597 (+63.52%) | Filing |
| 2024-11-15 4:05 pm Purchase | 2024-11-13 | 13D | Avenue Therapeutics, Inc. ATXI | Fortress Biotech Inc. FBIO | 180,425 8.900% | 180,425 (New Position) | Filing |